Post by
N0taP00p on Nov 30, 2022 12:08am
Last thought before sleeping
Where's the stock headed tomorrow? Set aside all your conspiracy theories for the moment. Unless this company goes on a PR offensive using available means (Dr Kamat, Dr. MacFarland, etc), will people really understand how this compares with other solutions? Many of you are assuming the data will pull, no compel, the analyst moths to the light. I am not so sure but hope so. My gut says that this will run if it gets into the FDAs Frontrunner program. Hooo boy, wouldn't that be fun.
Comment by
Legit62 on Nov 30, 2022 5:42am
I would want to believe that our name is spreading in the urology sector, which will then spread to other sectors of cancer treatment arena. But i also agree a little more PR would be great, Im also sure big Pharma is very well aware of us and its just a matter of time before they scoop in. A big fat buyout in spring would be great, less thinking involved for us
Comment by
Legit62 on Nov 30, 2022 5:45am
Project FrontRunner aims to improve the evidence base for cancer therapies by promoting trial designs and clinical development and regulatory approaches (e.g., accelerated approval pathway) that help generate data from gold standard randomized controlled trials to support the safe and effective use of cancer therapies ...Nov 9, 2022